MedPath

18F-FC-303

Generic Name
18F-FC-303

Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer

Phase 3
Recruiting
Conditions
Prostate Cancer
Interventions
First Posted Date
2023-08-25
Last Posted Date
2023-10-23
Lead Sponsor
HTA Co., Ltd.
Target Recruit Count
267
Registration Number
NCT06011304
Locations
🇨🇳

Sun Yat-sen University Cancer Center, Guangzhou, China

© Copyright 2025. All Rights Reserved by MedPath